NEW YORK (GenomeWeb News) – Epigenetic programs tend to become increasingly out of whack in B-cells as lymphoma develops, progresses, and becomes more aggressive, a new study suggests.

As they reported online last night in PLoS Genetics, researchers from the University of Colorado, Weill Cornell Medical College, the Dana-Farber Cancer Institute, and elsewhere used custom arrays and methylation assays to compare the DNA methylation profiles in normal B-cell samples and samples from the two most common subtypes of non-Hodgkin lymphoma.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Apr
03
Sponsored by
Dovetail Genomics

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.